Terbutaline ,Bromhexine Hydrochloride ,Guaiphenesin & Menthol

MUCOVIB

COMPOSITION
Terbutaline1.25 MG
Bromhexine Hydrochloride2 MG
Guaiphenesin50 MG
Menthol0.5 MG
SPECIFICATION
FORMSYRUP
PACKING100ml
PACKING TYPE
MRP49.9

DESCRIPTION

Terbutaline Sulphate + Guaiphenesin + Bromhexine Hydrochloride + Menthol Suspension:
Terbutaline Sulphate is a selective beta2 -adrenergic agonist which predominantly stimulates beta2-receptors, thus producing relaxation of bronchial smooth muscle. Guaiphenesin, by increasing respiratory tract fluid, reduces the viscosity of tenacious secretions and acts as an expectorant. Bromhexine HCl is intended to support the body’s mechanisms for clearing mucus from the respiratory tract. It is secretolytic, increasing the production of serous mucus in the respiratory tract and makes the phlegm thinner and less viscous Menthol is also classified as a expectorant.
RATIONALE OF COMBINATION
Terbutaline sulphate relaxes bronchial muscles and Guaiphenesin along with Menthol acts as a expectorant reducing the viscosity and helps to loosens mucus in your lungs. Whereas,
Bromhexine is an expectorant/mucolytic agent. Bromhexine is not available in the United States. It is marketed under the trade name Bisolvon(R) in Germany, England, Belgium, France, Italy, Netherlands, Norway, Sweden, Australia, and South Africa.

INDICATION

Increased heart rate
Palpitations
Dizziness
Headache
Drownsiness
Vomitting/Nausea
Gastrointestinal discomfort.

INDICATION

Cough associated with Acute and Chronic Bronchitis
Asthmatic Bronchitis
Emphysema, Active and Passive Smoking
Pulmonary TB
Other Bronchospastic Disorders